Accuracy of a High Prostate-Specific Antigen Level for Prostate Cancer Diagnosis upon Initial Biopsy in Korean Men
0
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
Purpose: This study aimed to evaluate the cancer detection rate in a Korean population with prostate-specific antigen (PSA) levels greater than or equal to 20.0ng/mL. Materials and Methods: A total of 174 men 50 to 79 years old (median 69) included in the study. The median prostate volume of the patients was 44.8mL (range 14.1 to 210.0) and their serum PSA ranged from 20.0 to 9725.0ng/mL (median 44.8). Results: Of 174 men 141 (81.0%) were diagnosed with prostate cancer on initial biopsy. In the total number of patients, the positive predictive value (PPV) was 62.9% for PSA 20 to 29.9, 72.7% for PSA 30 to 39.9 and 100% for PSA 40 to 49.9 ng/mL. In patients with an abnormal digital rectal examination (DRE), the values for these PSA ranges increased to 89.5%, 91.7% and 100%, respectively. The PPV was 81.0% for PSA cutoff of 20, 89.2% for a cutoff of 30, 95.4% for a cutoff of 40, and 94.7% for a cutoff of 50 ng/mL. In conjunction with an abnormal DRE, the values for these PSA cutoffs increased to 95.9%, 98.1%, 100%, and 100%, respectively. Conclusion: Our data suggest the ability to predict the presence of prostate cancer reliably on initial biopsy when PSA threshold is greater than or equal to 50ng/mL. This PSA threshold may be lowered to 40ng/mL in the presence of an abnormal DRE. In Korean men with high PSA, the detection rate of prostate cancer on biopsy appears to be comparable to that for American men.
참고문헌 (18)
- Carter HB, "Prostate cancers in men with low PSA levels-must we find them?", 350, pp.292~294 (2004)
- Richie JP, "Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer", pp.2031~6
- Cooner WH, "Prostate cancer detection in a clinical urological practice by ultrasonography", pp.1146~52
- Heyns CF, "Serum prostate-specific antigen as surrogate for the histological diagnosis of prostate cancer", 91, pp.685~689 (2001)
- Gerstenbluth RE, "The accuracy of the increased prostate specific antigen level (greater than or equal to 20ng.", ml.) in predicting prostate cancer: is biopsy always required?, 2002, pp.168, 1990~1993
- Masumori N, "Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries", 155, pp.1324~1327 (1996)
- Ku JH, "Race-specific reference ranges of serum prostate-specific antigen levels in countries with a low incidence of prostate cancer", 97, pp.69~72 (2006)
- Kim JW, "Can a 12 core prostate biopsy increase the detection rate of prostate cancer versus 6 core?: a prospective randomized study in Korea", 45, pp.671~675 (2004)
- Yang WJ, "Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study", 67, pp.333~336 (2006)
- Egawa S, "Results of transrectal ultrasound- guided biopsies and clinical significance of Japanese prostate cancer", 28, pp.666~672 (1998)
- Song JM, "Prostate- specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic Korean men", 46, pp.414~424 (2005)
- Labrie F, "Serum prostate specific antigen as pre-screening test for prostate cancer", pp.846~52
- Orozco R, "Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States", 51, pp.186~195 (1998)
- Shiraishi T, "Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986", pp.683~7
- Haas GP, "The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients", pp.379~85
- Shibata A, "Serum levels of prostate-specific antigen among Japanese-American and native Japanese men", 89, pp.1716~1720 (1997)
- Hsing AW, "International trends and patterns of prostate cancer incidence and mortality", 85, pp.60~67 (2000)
- Roberts RO, "Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997", 59, pp.79~84 (2002)